We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ZETA:NYSEZeta Global Holdings Corp. Analysis

Data as of 2026-08-08 - not real-time

$26.64

Latest Price

9/10Risk

Risk Level: High

Executive Summary

At $26.64, Zeta Global Holdings Corp. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. The last 30 days have gained 49.0%. Relative strength is 68.3 — approaching overbought — and the MACD signal is bullish. The recent range runs from support at $19.07 up to resistance at $28.50.
On valuation the read is fair — earnings multiple of 22.1 versus a 36.1 sector average, below the peer group. The average analyst target implies 14.0% above today's level. Revenue is growing at 43.5% on a -0.1% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 65.5%, a beta of 2.35 and a maximum drawdown of 40.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
This one splits by horizon — buy in the near term, hold further out, at 3/10 long-term conviction.

Top Market Events

Zeta Global Holdings Corp. NYSE:ZETA is one of the 10 worst artificial intelligence stocks under $30 according to short...2dZeta Global: The Growth Is Finally Showing Up On The Bottom LineExcluding political candidate revenue and revenue...On June 30, Saken Ismailov from Freedom Broker initiated coverage of Zeta Global Holdings Corp.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 19.01
  • MACD momentum is positive

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 22.1 versus sector average of 36.1
  • Trading above the 200-day average of 19.01

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 22.1 versus sector average of 36.1
  • Negative profit margin of -0.1%
  • Analyst targets imply +14.0% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth43.50%
Profit Margin-0.14%
P/E Ratio22.1
ROE-0.27%
ROA2.60%
Debt/Equity23.77
P/B Ratio8.1
Op. Cash Flow$241.0M
Free Cash Flow$252.2M
Industry P/E36.1

Technical Analysis

TrendBullish
RSI68.3
Support$19.07
Resistance$28.50
MA 20$22.24
MA 50$21.40
MA 200$19.01
MACDBullish
VolumeIncreasing
Fear & Greed Index94.82

Valuation

Fair Value$35.44
Target Price$30.36
Upside/Downside13.95%
GradeFair
TypeGrowth

Risk Assessment

Beta2.35
Volatility65.52%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.